Livzon Pharmaceutical Group Inc (000513) — Cash Flow Reinvestment Rate
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Reinvestment Rate of 0.13x as of September 2025, reinvesting CN¥108.66 Million (capex CN¥108.66 Million ) from operating cash flow of CN¥853.59 Million. Explore Livzon Pharmaceutical Group Inc (000513) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Livzon Pharmaceutical Group Inc Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Livzon Pharmaceutical Group Inc across 26 annual periods. Also explore total assets of Livzon Pharmaceutical Group Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Livzon Pharmaceutical Group Inc (1999–2024)
Year-by-year capital reinvestment analysis for Livzon Pharmaceutical Group Inc. For live market cap and broader valuation context, see Livzon Pharmaceutical Group Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.22x | CN¥656.96 Million | CN¥2.98 Billion | CN¥570.16 Million | ▼ -51.0% |
| 2023 | 0.45x | CN¥1.53 Billion | CN¥3.39 Billion | CN¥820.45 Million | ▼ -42.4% |
| 2022 | 0.78x | CN¥2.17 Billion | CN¥2.77 Billion | CN¥940.15 Million | ▼ -25.0% |
| 2021 | 1.04x | CN¥1.98 Billion | CN¥1.90 Billion | CN¥1.31 Billion | ▲ +202.3% |
| 2020 | 0.35x | CN¥745.73 Million | CN¥2.16 Billion | CN¥646.98 Million | ▲ +52.6% |
| 2019 | 0.23x | CN¥399.55 Million | CN¥1.77 Billion | CN¥398.00 Million | ▼ -71.3% |
| 2018 | 0.79x | CN¥997.34 Million | CN¥1.27 Billion | CN¥474.47 Million | ▲ +32.8% |
| 2017 | 0.59x | CN¥779.77 Million | CN¥1.32 Billion | CN¥294.15 Million | ▼ -42.2% |
| 2016 | 1.03x | CN¥1.31 Billion | CN¥1.28 Billion | CN¥368.46 Million | ▲ +70.5% |
| 2015 | 0.60x | CN¥557.97 Million | CN¥927.79 Million | CN¥477.13 Million | ▼ -35.2% |
| 2014 | 0.93x | CN¥665.52 Million | CN¥717.39 Million | CN¥665.52 Million | ▼ -55.6% |
| 2013 | 2.09x | CN¥920.00 Million | CN¥439.99 Million | CN¥920.00 Million | ▲ +62.9% |
| 2012 | 1.28x | CN¥762.30 Million | CN¥593.96 Million | CN¥762.30 Million | ▲ +160.6% |
| 2011 | 0.49x | CN¥348.83 Million | CN¥708.20 Million | CN¥348.83 Million | ▼ -7.4% |
| 2010 | 0.53x | CN¥336.95 Million | CN¥633.30 Million | CN¥336.95 Million | ▲ +100.4% |
| 2009 | 0.27x | CN¥131.41 Million | CN¥494.88 Million | CN¥131.41 Million | ▲ +21.4% |
| 2008 | 0.22x | CN¥75.52 Million | CN¥345.18 Million | CN¥75.52 Million | ▼ -40.4% |
| 2007 | 0.37x | CN¥91.28 Million | CN¥248.55 Million | CN¥91.28 Million | ▼ -53.9% |
| 2006 | 0.80x | CN¥180.45 Million | CN¥226.46 Million | CN¥180.45 Million | ▼ -50.0% |
| 2005 | 1.59x | CN¥256.72 Million | CN¥161.07 Million | CN¥256.72 Million | ▲ +97.4% |
| 2004 | 0.81x | CN¥146.48 Million | CN¥181.46 Million | CN¥146.48 Million | ▲ +133.9% |
| 2003 | 0.35x | CN¥103.56 Million | CN¥300.01 Million | CN¥103.56 Million | ▼ -28.8% |
| 2002 | 0.48x | CN¥103.62 Million | CN¥213.65 Million | CN¥103.62 Million | ▼ -7.7% |
| 2001 | 0.53x | CN¥81.48 Million | CN¥155.15 Million | CN¥81.48 Million | ▼ -67.1% |
| 2000 | 1.60x | CN¥61.49 Million | CN¥38.52 Million | CN¥61.49 Million | ▲ +435.3% |
| 1999 | 0.30x | CN¥73.44 Million | CN¥246.23 Million | CN¥73.44 Million | — |